6-(6-(((lR,2R,3S,5S)-2-fluoro-9-azabicyclo[3.3.1]nonan-3-yl)(methyl)amino)pyrida zin-3- yl)-2- methylbenzo[d]oxazol-5-ol as a splicing modulator for the treatment of neurological diseases
AU2026207956A1Pending Publication Date: 2026-08-06SKYHAWK THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- SKYHAWK THERAPEUTICS INC
- Filing Date
- 2026-07-21
- Publication Date
- 2026-08-06
Abstract
20 26 20 79 56 21 J ul 2 02 6 2 0 2 6 2 0 7 9 5 6 2 1 J u l 2 0 2 6 A B S T R A C T
Need to check novelty before this filing date? Find Prior Art